ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 1437

Journal of Clinical & Experimental Pathology received 1437 citations as per Google Scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Cosmos IF
  • Ulrich's Periodicals Directory
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
  • world cat
  • journal seek genamics
  • j-gate
  • esji (eurasian scientific journal index)
Share This Page

Multifocal invasive ductal carcinoma with divergent expression of biological parameters in male with neurofibromatosis-1: A rare association

5th International Conference on Pathology

Snehal Shankar Sonawane, Kristy Waite and Steven Thompson

University of Illinois at Chicago, USA Summa Health System, USA

Posters & Accepted Abstracts: J Clin Exp Pathol

DOI: 10.4172/2161-0681.C1.020

Abstract
Approximately 4-40% of the male breast cancers have been attributed to various genetic mutations like PTEN, BRCA, AR and CHEK2 gene. Here we present a rare association of male breast cancer with Neurofibromatosis-1 (NF-1) in a 56 year-old white male with a history of NF-1, who discovered a mass in his right breast. Breast imaging showed a right breast mass (6.9Ã?Â?2.0 cm) with enlarged axillary lymph nodes. Biopsy revealed invasive ductal carcinoma. He underwent neoadjuvant chemotherapy with modified radical mastectomy. Gross examination revealed two lesions, one in the center of the breast, posterior to the nipple (2.5 cm), other in the middle of the outer quadrants (1.5 cm). Microscopic examination revealed multifocal invasive ductal adenocarcinoma, Nottingham Grade 3, pathological stage IIA, pT2 (m), pN0. Immunohistochemistry for estrogen (ER) and progesterone (PR) were negative with equivocal HER2 in the smaller nodule. The larger mass in the center was ER+, PR+ with equivocal HER2. HER2 FISH studies showed amplification in both masses. Male breast cancer is rare (<1%) of all breast carcinomas with a mean age of diagnosis between 60-70 years. Literature search showed only 4 male patients who had NF-1 and subsequently developed breast cancer with average age of onset of 52 years. The NF1 mutation could have predisposed these individuals to an early development of breast cancer with high grade and advanced stages. NF-1 is associated with a negative regulation of the RAS signaling pathway, it will be intriguing to find out if novel drugs targeting the Ras pathway can be of use in treatment of this specific subset of breast cancer. There is also increasing evidence that depletion of NF1 protein makes the drug tamoxifen less sensitive and also leads to the resistance in human breast cancer cell lines.
Biography

Snehal Shankar Sonawane has completed her Medical School at Government Medical College Miraj and has done Diplomate of National Board in Pathology from RCSM Government Medical College Kolhapur. She is presently working as Pathology Resident Physician at University of Illinois at Chicago. Her research work is in area of ‘Dry eye disease’ and is published in reputed journals.

Email: snehal@uic.edu

Top